Azenta Life Sciences Announces Fiscal 2022 First Quarter Earnings Conference Call and Webcast

Rhea-AI Summary

Azenta, Inc. (Nasdaq: AZTA) will announce its fiscal 2022 Q1 earnings on February 8, 2022, after market close. A conference call to discuss the results will be held the same day at 4:30 p.m. ET. Investors can access the live webcast on Azenta's website, with a replay available on February 9 at 8:30 a.m. ET. The company, a leader in life sciences solutions, has rebranded from Brooks Automation, Inc. and is in the process of selling its Semiconductor Solutions Group business, which is classified as discontinued operations for reporting purposes.

Positive

• Company rebranding enhances market presence as Azenta, Inc. (Nasdaq: AZTA).
• Strong focus on life sciences solutions with potential for impactful breakthroughs.
• Pending divestiture of Semiconductor Solutions Group could streamline operations.

Negative

• Transition to Azenta includes risks of revenue fluctuations during rebranding.
• Pending sale of Semiconductor Solutions Group may result in short-term operational disruptions.

CHELMSFORD, Mass, Jan. 24, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal 2022 first quarter earnings which ended on December 31, 2021 on Tuesday, February 8, 2022 after the market closes.

The Company will host a conference call and live webcast to discuss its financial results on the same day, Tuesday, February 8, 2022 at 4:30 p.m. Eastern Time.  To participate in the conference call, please dial 800-584-1012 for domestic callers and +1-212-231-2907 for international callers.

Analysts, investors and members of the media can access the live webcast via the Azenta website at https://investors.azenta.com/events.  A replay will be available beginning at 8:30 a.m. ET on February 9, 2022.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. As of December 1st, the company changed its name and ticker to Azenta, Inc. (Nasdaq: AZTA) from Brooks Automation, Inc, (Nasdaq: BRKS).

In addition, the company operates the Semiconductor Solutions Group business, an industry-leading provider of semiconductor manufacturing automation and collaborative robotics solutions worldwide. On September 20, 2021, the Company announced the pending sale of this business to Thomas H. Lee Partners. Due to the pending divestiture, the Company began reporting the Semiconductor Solutions Group business as discontinued operations in its fiscal year-end earnings announcement. 

Azenta is headquartered in Chelmsford, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:

Sara Silverman
Director, Investor Relations
Azenta Life Sciences
978.262.2635
sara.silverman@azenta.com

Sherry Dinsmore
Azenta Life Sciences
978.262.2400
sherry.dinsmore@azenta.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-life-sciences-announces-fiscal-2022-first-quarter-earnings-conference-call-and-webcast-301466120.html

SOURCE Azenta

FAQ

When will Azenta, Inc. announce its Q1 earnings for fiscal 2022?

Azenta will announce its fiscal 2022 Q1 earnings on February 8, 2022, after market close.

How can investors access the Q1 earnings conference call for Azenta?

Investors can access the conference call on February 8, 2022, at 4:30 p.m. ET by dialing 800-584-1012 for domestic calls or +1-212-231-2907 for international calls.

What significant changes has Azenta, Inc. undergone recently?

Azenta rebranded from Brooks Automation, Inc. and is in the process of selling its Semiconductor Solutions Group business, now reported as discontinued operations.

What are the implications of the Semiconductor Solutions Group sale for Azenta?

The sale may streamline Azenta's operations but could also lead to short-term revenue fluctuations and operational challenges.